ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Abstract Number: PB0650

    Validation of a New Point-of-Care Platelet Counter

    M. Nagy1, R. van Oerle1, S. Fazaeli2, J. Sherry2, P.L.A. Giesen3, C. Lauwerijssen2, G. Mimnagh2, H. ten Cate1, H.M. Spronk1

  • Abstract Number: PB0168

    Validation of a Non- Sensitive aPTT Reagent for the Presence of Anti-Phospholipid Abs (Lupus Anti-Coagulant)

    S. Nakav1, Y. Sulayev2, T. Mendez2, A. Bragg1, A. Ben-Dor2, I. Pickholtz1, I. Kat2

  • Abstract Number: PB0568

    Validation of a Warfarin Dose Prediction Model: A Single Center Retrospective Study

    A. Lubetsky1,2, O. Cohen1,2, G. Kenet1,2

  • Abstract Number: PB1011

    Validation of an Algorithm to Identify Hemophilia A Patients in Administrative Database

    A.U. Alam, M. Karkhaneh, C. Wu, H. Sun

  • Abstract Number: PB0685

    Validation of the Atellica COAG 360 Coagulation Analyzer

    E. Krstova Krajnc, M. Šega

  • Abstract Number: PB0692

    Validation of the ROTEM PLATELET® Module as an Impedance Platelet Aggregation Test Compared to the Gold Standard Test: Conventional Platelet Aggregation

    J. Guerra, V.F. Aranda, M.M.S. Oliveira, A.O. Santos, D.R.C. Mello, C.E.A. Mendes, B.G.N. Fogo, M. Oliveira, C.M. Ito, E.R.L.S. Junior, O. Ricardi, R.M.C. Penteado

  • Abstract Number: PB1253

    Validity and Reliability of Self-Administered Thai Pediatric Bleeding Questionnaire (TPBQ) Application to Predict Risk of Bleeding in Pediatric Bleeding Disorders

    S. Suwanwijit, D. Sosothikul

  • Abstract Number: PB1033

    Value of Super Microvascular Imaging and Contrast-enhanced Ultrasound in Evaluating the Neovascularization of Synovial Hypertrophy in Hemophilia Joints

    Y. Li1, Y. Zhang1, C. Xu1, J. Sun2, Y. Gao1, H. Liu1, M. Fei1

  • Abstract Number: PB0622

    Variability in Dabigatran and Apixaban trough Concentrations

    P. Della Valle1, L. Pozzi2, E. Pattarini3, L. Tomassini1, A. Fattorini1, L. Crippa1, A. D'Angelo1

  • Abstract Number: PB1239

    Variability in Diagnosis and Management of Immune Thrombocytopenia in Children: Real Life According to Spanish Pediatricians and Hematologists

    R. Berrueco1,2, J.L. Dapena3, E. Monteagudo4, I. Astigarraga5, A. Cervera6, M.A. Dasí7, A. Sastre8, E. Sebastian9

  • Abstract Number: PB2430

    Variability in Exposure to Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Hospitalised Patients

    E. Kampouraki1, P. Avery2, H. Wynne3, F. Kamali1,3

  • Abstract Number: PB1672

    Variability in Platelet Function among Patients with von Willebrand Disease Type 2B (VWD2B): Focus on Patients Historically Diagnosed with Montreal Platelet Syndrome (Historic-MPS)

    M. Rand1, P. James2, H. Wang1, K.W.A. Bang3, M. Bowman2, S. Cloutier4, S. Jackson5, M.-C. Poon6

  • Abstract Number: PB2392

    Variability of Management of Peripheral Catheter-Related Upper Extremity Superficial Vein Thrombosis

    H.L.A. Yuen1,2, W. Fang2, S. Chunilal1,2

  • Abstract Number: PB0604

    Variable Findings in One-Stage Clotting Assays in a Patient with Waldenstrom’s Macroglobulinaemia

    S. Platton1, A. McCormick2, A. Riddell3, E. Bromidge2, C. Fenoo4, G.W. Moore2,5, C. Boshier4

  • Abstract Number: PB1507

    Variants in the LLR5 Domain Confer to GPIbα Increased Affinity for VWF: A Novel Case of Platelet-type von Willebrand Disease

    L. Bury, E. Falcinelli, H. Kuchi Bhotla, A.M. Mezzasoma, G. Guglielmini, P. Gresele

  • Abstract Number: PB1446

    Variants of GFI1B: Phenotype/Genotype of a Series of 9 New Cases

    A. Vincenot1, E. Lainey2, V. Barbay3, E. Demaistre4, D. Desprez5, C. Lavenu-Bombled6, A.M. Ronchetti7, M.F. Hurtaud1

  • Abstract Number: PB1893

    Varied Presentations of TTP

    A. Aribandi, C.S. Ranjith

  • Abstract Number: PB2288

    Vein Thrombosis after an Osteopathy Session

    V. Kieffer

  • Abstract Number: PB2297

    Venous Involvement in Behcet Disease: Clinical Spectrum and Predictive Factors

    M. Kechida, A. Fraj, S. Daada, R. Klii, S. Hammami, I. Khochtali, M. Sassi

  • Abstract Number: PB2449

    Venous Recanalization after a Thromboembolic Event in a North Afriacan Population

    M. Mrouki, S. Zrida, Y. Cherif, S. Derbel, F. Ben Dahmen, M. Abdallah

  • Abstract Number: PB2174

    Venous Thromboembolic Risk in Ambulatory Cancer Patients: Awareness Needed!

    S. Lopes1, J. Marinho2, L. Vieira1, F. Azevedo1, I. Leão2, E. Neto2, Í. Alonso1, L. Morais2, J. Marques1, A. Barroso3, H. Coelho4, E. Mesquita5, T. Costa2, D. Ferreira1

  • Abstract Number: PB2279

    Venous Thromboembolism (VTE) Events in Elective and Emergency Orthopaedic Surgery in a Large Teaching Hospital 2011 to 2019

    H. Rowswell, T. Nokes

  • Abstract Number: PB2126

    Venous Thromboembolism (VTE) Events with Cancer as a Risk Factor in a Teaching Hospital: 2015-2019

    H. Rowswell, T. Nokes

  • Abstract Number: PB1294

    Venous Thromboembolism (VTE) in Children with Community-acquired Staphylococcus Aureus Bacteremia (CA-SAB) in Children: Risk Factors and Prevalence Study from a Single Pediatric Tertiary Care Center in Argentina

    C. Cervio1, M. Hepner1, E. Annetta1, G. Pieroni1, M.B. Bianco1, J.P. Frontroth1, A. Smigliani2, M.G. Perez2, S. Ruvinsky2, G. Sciuccati1

  • Abstract Number: PB2141

    Venous Thromboembolism in Patients with Cancer in Palliative Care

    S. Ayende-Perez1, A. Peña-Nieves2, A. Arcos1, P. Baz1, E. Verastegui-Avilés1, G. Cesarman Maus1

  • Abstract Number: PB2372

    Venous Thromboembolism in Patients with Renal Transplantation

    D. Poli1, L. Migliaccio2, E. Antonucci2, L. Biancone3, G. Ghigliotti4, G. La Manna5, A. Ranghino6, P. Rigotti7, S. Tentori8, M. Zanazzi2, G. Palareti2

  • Abstract Number: PB2421

    Venous Thromboembolism Profile and Management Differences between Sexes in a RIETE’s Hospital in Brazil

    A.T. Rocha1,2, M. Pereira de Oliveira1, A.L. Emídio de Souza1

  • Abstract Number: PB2242

    Venous Thrombosis-dominant Congenital Dysfibrinogenemia Presenting with Cerebral Venous Sinus Thrombosis

    H.I. Lim, M.T. DeSancho

  • Abstract Number: PB/CO07

    Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis

    R. Rosovsky1, A. Li2, A. Desai3, D. Shah4, J. Fu5, S. Gulati6, R. Zon7, M. Thompson8, P. Grivas9, G. de Lima Lopes10, Y. Shyr11, J. Warner11, A. Khaki9, T. Choueiri12, S. Peters13, D. Rivera14, B. Rini11, G. Lyman15, J. Connors16, N. Kuderer17, on behalf of the COVID-19 and Cancer Consortium (CCC19)

  • Abstract Number: PB1962

    Vessel-On-A-Chip Model Revealing Rapid Offset and Onset Mechanisms of Collagen- and Thrombin-Induced Platelet Activation

    I. Provenzale, S.L.N. Brouns, D.I. Fernández, P.E.J. van der Meijden, J.W.M. Heemskerk

  • Abstract Number: PB1626

    Video Rate, High Contrast Morphological Imaging of Blood Thrombus using Label – Free Coherent Optical Scattering and Interferometry (COSI) Microscopy

    Y. Zheng1, S.J. Montague2, Y.J. Lim1,2, T. Xu1, E.E. Gardiner2, W.M. Lee1,2

  • Abstract Number: PB2374

    Visualization of Thrombin Formation on Activated Platelets and Fibrin Formation in Venous Flow Condition

    N. Sugita1, H. Hirakata2, K. Inoue2, K. Koike2

  • Abstract Number: PB1054

    Vitamin D Status and Risk of Osteoporosis in Hemophilia Patients

    M. Zakaria, M. Badr

  • Abstract Number: PB1924

    Vitamin K Antagonist (VKA) Monitoring Using Point of Care Testing (POCT) in Patients with Antiphospholipid Syndrome (APS)

    M. Masucci1, J. Martin1, E. Shingleton1, A. Li Kam Wa1, Z. Mahir2, K. Breen1,2

  • Abstract Number: PB2058

    Vitamin K Antagonists Dosing According to Pharmacogenetics

    E. Ristovska1, T. Makarovska Bojadjieva1, E. Velkova2, V. Dejanova1, E. Petkovic1, R. Grubovic1

  • Abstract Number: PB0313

    VMX-C001 Is a Reversal Agent for FXa-inhibiting DOACs and Displays a Favorable Pharmacokinetic and Pharmacodynamic Profile

    D. Verhoef1,2, M. Schreuder2, K.L. Cheung2, M.H.A. Bos2, P.H. Reitsma1,2

  • Abstract Number: PB1546

    von Willebrand Disease Combined with Other Coagulation Defects: Experience at a Single Reference Coagulation Laboratory in Iran

    O. Seidi Zadeh, M. Ahmadinejad, S. Homayoun, M. Mojtabavi, S. Mohsenian

  • Abstract Number: PB0502

    Von Willebrand Disease Type 1 Is Associated with Number of Rare Nonsynonymous Variants in the VWF Gene

    B. Sadler1, P. Christopherson2, R. Montgomery2, J. Di Paola1, Zimmerman Program Investigators

  • Abstract Number: PB0146

    Von Willebrand Factor (VWF) Deficiency Leads to Altered Angiogenesis in the Gastrointestinal Tract

    M. von Depka1, S. Lehner1, M. Ekhlasi-Hundrieser1, C. Pfarrer2, C. Detering1, K. Kaiser1,2

  • Abstract Number: OC 01.1

    von Willebrand Factor as a Predictor of Mortality and its Target Concentration Dependent Inhibition by BT200 Aptamer in Patients Treated with Potent ADP Receptor Blockers

    K. Kovacevic1, B. Jilma1, S. Zhu2, J. C. Gilbert2, M.-P. Winter3, A. Toma3, I. Lang3, C. Hengstenberg3, J. Siller-Matula4

  • Abstract Number: PB0073

    Von Willebrand Factor in Stroke and Non-valvular Atrial Fibrillation Patients

    M.E. Viveros-Sandoval1, L. Garcia-Quezada1, S.E. Lopez Castaneda1, A. Arauz-Gongora2, C.A. Arean-Martinez3

  • Abstract Number: PB0157

    von Willebrand Factor Levels and Expression Pattern Are Altered in Response to Aging

    P. Alavi1, R. Yousef Abdualla1, S. Bourque2, J. Nagendran3, N. Jahroudi1

  • Abstract Number: PB1552

    von Willebrand Factor Propeptide: Useful Diagnostic Add-On to Differentiate von Willebrand Disease Based upon Increased von Willebrand Factor Clearance

    O. Tiebel1, K. Trautmann-Grill2, S. Marten2, R. Knöfler3

  • Abstract Number: PB1592

    Von Willebrand’s Disease: A Diagnostic Evaluation Using Current Guidelines

    E. Bar1, S. De Soysa1, L. Huang1, E. Symington2

  • Abstract Number: PB2204

    VTE and its complications: A Real World View Daryl Pollock, RN, MN CNS Thrombosis/Haemostasis

    D. Pollock

  • Abstract Number: PB2353

    VTE Prophylaxis Performance in a Tertiary and Secondary Level Hospital in Ireland

    A. Talbot, L.Y. Tan, R. Tyrrell, M. Mustafa, Y. Ghanem, M. Watts

  • Abstract Number: PB2477

    VTE Treatment in Routine Clinical Practice: A Pre-specified Combined Evaluation of XALIA and XALIA-LEA with Additional Analyses of Special Patient Populations

    S. Haas1, L.G. Mantovani2,3, R. Kreutz4, D. Monje5, J. Schneider5, E. Zell6, M. Tamm7, M. Gebel7, J.-P. Bugge5, W. Ageno8, A.G.G. Turpie9

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.